ReleaseWire Connect

Though m-Commerce remains a small proportion of both online spending and total retail, its rapid growth and the increasing use of mobiles by consumers as part of the shopping process means it is an area that retailers cannot afford to ignore. This report examines all aspects of the role mobile phones are playing in retail, to help you gain a complete understanding of this crucial trend.

GBI Research has released its research, “Clinical Trial Recruitment Strategies in Oncology – Online Recruitment Methods and Use of IT – enabled Patient Management Systems will Reduce Recruitment Time and Cost”, which provides insights into recruitment strategies, challenges and solutions for on-time recruitment in oncology trials. The report also examines case studies to illustrate enhanced recruitment in a shorter time.

The report will provide an in-depth analysis of the power market of selected African countries (South Africa, Algeria, Egypt, Tunisia, Libya, Nigeria and Mozambique and others).

GBI Research has released its latest research, “Oil and Gas Enhanced Production Services Industry to 2015 - Enhanced Oil Recovery Proving to be a Key Solution for Tapping Unconventional Reservoirs and Depleting Oil Fields”. The study, which is an offering from the company’s Energy Research Group, provides an in-depth analysis of the oil and gas enhanced production services market worldwide and highlights the various concerns, key trends, along with major upstream deals in the upstream exploration and production sector. The report provides forecasts for the oil and gas enhanced production services industry to 2015. The report also provides segmental forecasts of the oil and gas enhanced production services industry by segment type and mentions the technology overview of each segment. Profiles of major oilfield services companies providing enhanced production services are also provided. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

GBI Research has released its latest research “Lifestyle Disorders Market to 2016 – Limited Pipeline Products and Slow Progress in R&D are Major Concerns”, which essentially provides insights on lifestyle disorders therapeutics sales and price forecasts until 2016. The report also examines the global lifestyle disorders therapies treatment usage patterns. In addition, the geographical distribution of lifestyle disorders therapies across the US, the top five countries in the European region and Japan are also provided in the report. The report also includes insights into the lifestyle disorders Research and Development (R&D) pipeline and the potential future blockbusters up to 2016. The report provides an in-depth analysis of the top five lifestyle disorders therapeutic indications, which are erectile dysfunction, obesity, alopecia, smoking cessation and alcohol dependence.

GBI Research has released its latest research “Lifestyle Disorders Market to 2016 – Limited Pipeline Products and Slow Progress in R&D are Major Concerns”, which essentially provides insights on lifestyle disorders therapeutics sales and price forecasts until 2016. The report also examines the global lifestyle disorders therapies treatment usage patterns. In addition, the geographical distribution of lifestyle disorders therapies across the US, the top five countries in the European region and Japan are also provided in the report.

GBI Research’s “Smartphone Integrated Circuits (IC) Market to 2020 – Greater Appetite for Connectivity ICs Including Wi-Fi, Bluetooth and GPS will Increase Demand“ report provides an incisive analysis of the ICs used in smartphones. The report presents the market size of smartphone ICs such as baseband, application processor, GPS IC, Bluetooth IC, Sensors among others. Increasing user preference for advanced feature sets is expected to boost the demand for smartphone connectivity ICs in the near future.

GBI Research’s research, “Risk Evaluation and Mitigation Strategy (REMS) – Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS”, provides key data, information and analysis on the risk management and mitigation strategies, mandated by the FDA and being implemented by pharmaceutical companies.

GBI Research, the leading business intelligence provider, has released its latest research, “Technology Transfer Strategies – A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries”, which provides insights into global technology transfer strategies landscape.

GBI Research’s report, “Innovations in Protein Kinase Therapies – Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology”, provides in-depth analysis of innovations in protein kinase therapies in the current pharmaceutical market.